Wegovy 2.4 mg

Wegovy 2.4 mg contains Semaglutide 2.4 mg, a once-weekly GLP-1 receptor agonist indicated for chronic weight management in adults with obesity or overweight who have at least one weight-related comorbidity, alongside a reduced-calorie diet and increased physical activity. In eligible regions, it may also be prescribed for certain adolescents with obesity under specialist supervision.

As the recommended maintenance dose, Wegovy 2.4 mg is typically reached after a gradual dose-escalation schedule (0.25 mg, 0.5 mg, 1 mg, and 1.7 mg) to improve treatment tolerability. Semaglutide helps regulate appetite by increasing satiety, reducing hunger, and slowing gastric emptying, supporting sustained weight loss when combined with healthy lifestyle modifications.

Manufactured under strict quality standards, Wegovy 2.4 mg is supplied by trusted pharmaceutical exporters to licensed importers, distributors, hospitals, pharmacies, and healthcare institutions worldwide. We provide export-grade packaging, complete regulatory documentation, competitive wholesale pricing, and reliable global shipping to regulated and semi-regulated markets.